These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31070290)

  • 21. Multivariate evaluation of Thyroid Imaging Reporting and Data System (TI-RADS) in diagnosis malignant thyroid nodule: application to PCA and PLS-DA analysis.
    Zhang T; Li F; Mu J; Liu J; Zhang S
    Int J Clin Oncol; 2017 Jun; 22(3):448-454. PubMed ID: 28220335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparison of Two Widely Used Risk Stratification Systems for Thyroid Nodule Sonographic Evaluation.
    Paker M; Goldman T; Masalha M; Shlizerman L; Mazzawi S; Ashkenazi D; Ghanayim R
    Isr Med Assoc J; 2021 Nov; 23(11):714-719. PubMed ID: 34811987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasonic Characteristics of Medullary Thyroid Carcinoma: Differential From Papillary Thyroid Carcinoma and Benign Thyroid Nodule.
    Lei R; Wang Z; Qian L
    Ultrasound Q; 2021 Apr; 37(4):329-335. PubMed ID: 33843826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of ACR TI-RADS combined with three-dimensional shear wave elastography in ACR TI-RADS 4 and 5 thyroid nodules.
    Hao L; Liu P; Ding C; Li J; Zhang Y
    Chin Med J (Engl); 2023 May; 136(10):1225-1230. PubMed ID: 37075764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shear wave elastography combined with the thyroid imaging reporting and data system for malignancy risk stratification in thyroid nodules.
    Liu Z; Jing H; Han X; Shao H; Sun YX; Wang QC; Cheng W
    Oncotarget; 2017 Jun; 8(26):43406-43416. PubMed ID: 28160573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Malignant Thyroid Nodules That Do Not Meet ACR TI-RADS Criteria for Fine-Needle Aspiration.
    Middleton WD; Teefey SA; Tessler FN; Hoang JK; Reading CC; Langer JE; Beland MD; Szabunio MM; Desser TS
    AJR Am J Roentgenol; 2021 Feb; 216(2):471-478. PubMed ID: 32603228
    [No Abstract]   [Full Text] [Related]  

  • 27. Discriminating Malignancy in Thyroid Nodules: The Nomogram Versus the Kwak and ACR TI-RADS.
    Xiao J; Xiao Q; Cong W; Li T; Ding S; Shao C; Zhang Y; Liu J; Wu M; Jia H
    Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1156-1165. PubMed ID: 32689870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the American College of Radiology Thyroid Imaging Reporting and Data System for Thyroid Nodule Malignancy Risk Stratification in a Pediatric Population.
    Lim-Dunham JE; Toslak IE; Reiter MP; Martin B
    AJR Am J Roentgenol; 2019 Jan; 212(1):188-194. PubMed ID: 30403525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in Thyroid Nodule Biopsies and Improved Accuracy with American College of Radiology Thyroid Imaging Reporting and Data System.
    Hoang JK; Middleton WD; Farjat AE; Langer JE; Reading CC; Teefey SA; Abinanti N; Boschini FJ; Bronner AJ; Dahiya N; Hertzberg BS; Newman JR; Scanga D; Vogler RC; Tessler FN
    Radiology; 2018 Apr; 287(1):185-193. PubMed ID: 29498593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign thyroid nodules classified as ACR TI-RADS 4 or 5: Imaging and histological features.
    Chen J; Ye D; Lv S; Li X; Ye F; Huang Y; Su Z; Lin Y; Xie T; Wen X
    Eur J Radiol; 2024 Jun; 175():111261. PubMed ID: 38493559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Efficiency of ACR-TIRADS Score for Differentiating Benign and Malignant Thyroid Nodules of Various Pathological Types.
    Xu Y; Pi J; Jinghu Y; Wang X; Xu D; Liu J
    Med Sci Monit; 2024 May; 30():e943228. PubMed ID: 38764217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SWE combined with ACR TI-RADS categories for malignancy risk stratification of thyroid nodules with indeterminate FNA cytology.
    Zhang WB; Li JJ; Chen XY; He BL; Shen RH; Liu H; Chen J; He XF
    Clin Hemorheol Microcirc; 2020; 76(3):381-390. PubMed ID: 32675401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ultrasonographic features of thyroid carcinoma of different sizes: comparison between medullary thyroid carcinomas and papillary thyroid carcinomas].
    Zhang D; Yang F; Wang Y; Mu JL; Wei XQ; Wei X
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):133-139. PubMed ID: 38418187
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction of classical versus non classical papillary thyroid carcinoma subtypes from cytology of nodules classified according to TIRADS.
    Scappaticcio L; Trimboli P; Bellastella G; Ferrazzano P; Clery E; Cozzolino I; Montella M; Fasano M; Pirozzi M; Ferrandes S; Docimo G; Ciardiello F; Franco R; Esposito K
    Endocrine; 2024 May; 84(2):560-570. PubMed ID: 38001322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of modified TI-RADS using contrast-enhanced ultrasound features for classification purposes in the differential diagnosis of benign and malignant thyroid nodules: A prospective and multi-center study.
    Zhou P; Chen F; Zhou P; Xu L; Wang L; Wang Z; Yu Y; Liu X; Wang B; Yan W; Zhou H; Tao Y; Liu W
    Front Endocrinol (Lausanne); 2023; 14():1080908. PubMed ID: 36817602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ACR TI-RADS, Kwak TI-RADS, ATA guidelines and KTA/KSThR guidelines in combination with SWE in the diagnosis of thyroid nodules.
    Zhang WB; Xu W; Fu WJ; He BL; Liu H; Deng WF
    Clin Hemorheol Microcirc; 2021; 78(2):163-174. PubMed ID: 33579829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS.
    Chen Z; Du Y; Cheng L; Zhang Y; Zheng S; Li R; Zhang W; Zhang W; He W
    Cancer Imaging; 2022 Aug; 22(1):41. PubMed ID: 35978376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance of the EU TI-RADS and ACR TI-RADS scoring systems in predicting thyroid malignancy.
    Chatti HA; Oueslati I; Azaiez A; Marrakchi J; Boukriba S; Mizouni H; Haouet S; Besbes G; Yazidi M; Chihaoui M
    Endocrinol Diabetes Metab; 2023 Jul; 6(4):e434. PubMed ID: 37327183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of TI-RADS and ATA classifications for predicting malignancy of thyroid nodules.
    Şahin M; Oguz A; Tuzun D; Akkus G; Törün GI; Bahar AY; Şahin H; Gül K
    Adv Clin Exp Med; 2021 Nov; 30(11):1133-1139. PubMed ID: 34510845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACR TI-RADS and ATA ultrasound classifications are helpful for the management of thyroid nodules located in the isthmus.
    Cao J; Huang W; Huang P; Huang Y
    Clin Hemorheol Microcirc; 2022; 80(4):463-471. PubMed ID: 34864651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.